Cargando…
Application of Neuromelanin MR Imaging in Parkinson Disease
MRI has been used to develop biomarkers for movement disorders such as Parkinson disease (PD) and other neurodegenerative disorders with parkinsonism such as progressive supranuclear palsy and multiple system atrophy. One of these imaging biomarkers is neuromelanin (NM), whose integrity can be asses...
Autores principales: | He, Naying, Chen, Yongsheng, LeWitt, Peter A., Yan, Fuhua, Haacke, E. Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086789/ https://www.ncbi.nlm.nih.gov/pubmed/36017746 http://dx.doi.org/10.1002/jmri.28414 |
Ejemplares similares
-
Locus coeruleus and substantia nigra neuromelanin magnetic resonance imaging differentiates Parkinson’s disease and essential tremor
por: Wang, Xinhui, et al.
Publicado: (2023) -
Automatic detection of neuromelanin and iron in the midbrain nuclei using a magnetic resonance imaging‐based brain template
por: Jin, Zhijia, et al.
Publicado: (2022) -
Stability of AI-Enabled Diagnosis of Parkinson’s Disease: A Study Targeting Substantia Nigra in Quantitative Susceptibility Mapping Imaging
por: Xiao, Bin, et al.
Publicado: (2021) -
Editorial: Quantitative Susceptibility Mapping in Neurodegeneration
por: Yan, Fuhua, et al.
Publicado: (2021) -
Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease
por: Cheng, Zenghui, et al.
Publicado: (2019)